The stock of the maker of glucose monitoring systems may be seeking a bottom but it isn't clear whether it has gotten there yet.
The Fed chairman is speaking before the Senate here on Tuesday and again could impact the direction of the market.
The outright removal of potential liquidity from the economy earlier than expected scares the living heck out of everyone who understands.
Let's look at my take on United Natural Foods vs. Value Line's take.
Let's look at the move in the Invesco QQQ Trust and where it could go from here.
We haven't moved past the either/or market -- and here's what that means for big-cap tech and growth stocks and breadth. Also, let's look at something shiny and precious.
Despite the intraday recovery, we had more poor action, and now it's all eyes on the Fed's chat with Congress.
TLRY posted promising earnings, but don't expect it smoke past its current levels for long.
Let's review the charts and indicators.
Traders often feel frozen when faced with a market like this. Here's a way to overcome inertia.